The team, composed of investigators from across the UK and US, will receive $25M to take on the challenge of cancer cachexia, the debilitating wasting condition responsible for up to …
Topic:
Cancer
-
-
The Advocate Urges a Navy Veteran or Person Who Was Exposed to Asbestos Prior to 1982 to Asbestos as a Machinist or Mechanic and Who Now Has Lung Cancer to Call the Lawyers at Danziger & De Llano-Compensation Might Be $100,000+
by Your NewsWASHINGTON, June 13, 2022 — The US Navy Veterans Lung Cancer Advocate is urging a Navy Veteran or person who had routine exposure to asbestos as a machinist or mechanic …
-
Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children’s Hospital of Philadelphia’s Transformative, Personalized Cancer Therapy
by Your NewsFrom Oscar-winning director Ross Kauffman and Oscar-nominated producer Robin Honan, the documentary follows three paths which come together in what became a pivotal moment in cancer history. The film traces …
-
(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) said it was awarding $215 million in first-year funding as part of reviving the erstwhile Obama administration’s Cancer Moonshot …
-
Georgia Man Pleads Guilty To Fraud And Kickback Scheme Involving Covid-19 And Cancer Genetic Testing
by DOJ PressNEWARK, N.J. – A Georgia man pleaded guilty today for his role in a conspiracy to commit health care fraud and receive kickbacks in connection with fraudulent testing claims for …
-
Strong T-cell response for blood cancer patients after vaccine; COVID breakthrough often serious for cancer patients
by ReutersBy Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19 and cancer presented at the annual meeting of the American Society of Clinical Oncology …
-
US Navy Veterans Lung Cancer Advocate Now Urges a Navy Veteran-Person Who Now Has Lung Cancer to Call the Lawyers at Danziger & De Llano If They Had Navy-Workplace Exposure to Asbestos Before 1982-Compensation May Exceed $100,000
by Your NewsWASHINGTON, June 6, 2022 — The US Navy Veterans Lung Cancer Advocate is urging a Navy Veteran or person who has been diagnosed with lung cancer within the last 12 …
-
FRANKFURT – An oral drug combination by Swiss pharmaceuticals company Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial. In …
-
By Natalie Grover LONDON – AstraZeneca and Daiichi Sankyo’s Enhertu extended survival by more than six months in patients with a form of advanced breast cancer compared to standard chemotherapy, …
-
By Nancy Lapid (Reuters) – The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology (ASCO) in …
-
By Michael Erman (Reuters) – Johnson & Johnson and AbbVie’s big-selling leukemia drug Imbruvica in combination with standard treatment kept a rare type of non-Hodgkin lymphoma in check for more …
-
Caris Life Sciences Pays over $2.8 Million to Settle False Claims Act Allegations from Delay in Submission of Genetic Cancer Screening Tests
by DOJ PressCaris Life Sciences, Inc. (Caris) has agreed to pay $2,886,674.86 to resolve allegations that it violated the False Claims Act in an alleged nationwide scheme to improperly bill Medicare for …
-
(Reuters) -The U.S. Food and Drug Administration said on Wednesday it has withdrawn its approval for TG Therapeutics Inc’s lymphatic cancer treatment Ukoniq over concerns of higher risk of death …
-
ABSECON, NJ (PRESS RELEASE) – On Friday May 27th, the Absecon Police Department and over 30 other Law Enforcement agencies from Atlantic and Cape May counties welcomed Devarjaye “DJ” Daniel …
-
By Ludwig Burger FRANKFURT -Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when the immunotherapy drug failed to slow progression of lung cancer …
-
PRESS RELEASE by Brooklyn District Attorney’s Office NEW YORK, NY – Brooklyn District Attorney Eric Gonzalez, together with New York State Attorney General Letitia James, today announced that a Staten …
-
Hackensack University Medical Center Offers an Innovative New Screening Option for Patients at High Risk for Pancreatic Cancer
by Your NewsPatients who are eligible will receive both an imaging test and a novel biomarker test that measures the immune system’s response to pancreatic disease in the blood. “The earlier cancer …
-
(Reuters) – Nektar Therapeutics said on Monday it would lay off about 70% of its workforce, or more than 500 employees, after stopping the development of its key cancer drug …
-
HOUSTON -Marathon Petroleum Chief Executive Michael Hennigan said on Thursday he will continue leading the largest U.S. crude oil refiner while he undergoes treatment for throat cancer, according to a …
-
NEW YORK CITY, NY – 10-year-old Devarjaye “DJ” Daniel has been sworn in as a police officer at his 387th agency, the New York City Police Department. In January, DJ …
-
To kick off the partnership, Freshly and Pink Ribbon Girls have launched a one-for-one Mother’s Day gifting program. Consumers who give their moms the gift of Freshly this holiday will, …
-
(Reuters) – Nektar Therapeutics said on Thursday it had stopped all trials involving its key cancer drug following its failure in multiple studies, dragging the drug developer’s shares down 23% in …
-
Chula Vista Woman Admits Faking Cancer While Attempting to Avoid Prison for Fraud Conviction
by DOJ PressSAN DIEGO – Ashleigh Lynn Chavez pleaded guilty in federal court today to Obstruction of Justice, admitting that she repeatedly forged doctor’s notes falsely indicating she had been diagnosed with …
-
John Theurer Cancer Center Treats First Patient in U.S. with Investigational New Treatment for Brain Cancer
by Your NewsDSP-0390, an investigational new agent developed by Cambridge, Massachusetts-based Sumitomo Dainippon Pharma Oncology, is an inhibitor of emopamil-binding protein (EBP), a molecule in cholesterol biosynthesis. DSP-0390 has not been approved …
-
Children’s Hospital of Philadelphia Establishes the Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy
by Your News“Cell and gene therapy is a major emphasis at CHOP. With this significant investment from Steve and Susan, CHOP is now positioned, unlike any other academic medical center, to leverage …